| Name | Title | Contact Details |
|---|---|---|
Ashok Chander |
Chief Technology Officer | Profile |
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Panoramic Health is the nation`s leading integrated value-based kidney care platform led by physicians. The company is committed to keeping nephrologists independent, relevant, and at the center of patient-care delivery; improving outcomes and slowing disease progression for CKD-ESKD patients. Panoramic Health`s value-based care delivery platform is driven by proprietary, predictive data analytics and clinical workflows underpinned by one of the world`s largest clinical CKD data warehouses that enable nephrologists to deliver better patient outcomes and value-based care.
MedFolio is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OMBS is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PRONERVE is a Broomfield, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.